Skip to Content

Clinical Services

The Section of Benign Hematology provides services for a broad range of blood disorders.

  • Bone marrow disorders—chemotherapy-induced myelosuppression; aplastic anemia; pure red cell aplasia; amegakaryocytic thrombocytopenia; diagnosis and treatment of treatment-related and de novo myelodysplastic syndrome; benign monoclonal gammopathy.
  • Red cell disorders—anemia; erythrocytosis; hemoglobinopathies; enzymopathies; porphyrias; hemophagocytic lymphohistiocytic disorders.
  • White cell disorders—neutropenia; functional disorders; leukocytosis; lymphohistiocytic disorders.
  • Platelet disorders—thrombocytopenia; platelet function disorders; thrombotic microangiopathies; platelet transfusions.
  • Bleeding disorders—acquired and congenital coagulopathies; sepsis with DIC; von Willebrand disease; use of replacement therapy (purified factors, FFP, fibrinogen, and cryoprecipitate); use of hemostatic drugs (ε-aminocaproic acid, DDAVP, recombinant activated factor VII); perioperative management of hemostasis and hemostatic risk.
  • Thrombotic disorders—venous thromboembolism; atherothrombosis; hypercoagulability; use of anticoagulant, antiplatelet and fibrinolytic drugs; perioperative management of thromboses; post-thrombotic syndrome.

Last updated July 6, 2009 (MN)

© 2015 The University of Texas MD Anderson Cancer Center